Pembrolizumab in relapsed or refractory Richter syndrome.

Authors

Philippe Armand
Niels Murawski
Daniel Molin
Jasmine Zain
Barbara Eichhorst
Zafer Gulbas
Eliza A Hawkes
John M Pagel, Swedish Center for Blood Disorders and Stem Cell Transplants, Swedish Cancer Institute, Seattle, WA, USAFollow
Tycel Phillips
Vincent Ribrag
Jakub Svoboda
Anastasios Stathis
Arkendu Chatterjee
Robert Orlowski
Patricia Marinello
Beth Christian

Document Type

Article

Publication Date

7-1-2020

Publication Title

British journal of haematology

Clinical Institute

Cancer

Department

Oncology

Department

Hematology

Recommended Citation

Armand, Philippe; Murawski, Niels; Molin, Daniel; Zain, Jasmine; Eichhorst, Barbara; Gulbas, Zafer; Hawkes, Eliza A; Pagel, John M; Phillips, Tycel; Ribrag, Vincent; Svoboda, Jakub; Stathis, Anastasios; Chatterjee, Arkendu; Orlowski, Robert; Marinello, Patricia; and Christian, Beth, "Pembrolizumab in relapsed or refractory Richter syndrome." (2020). Articles, Abstracts, and Reports. 3345.
https://digitalcommons.providence.org/publications/3345